WordNet
- a living organism characterized by voluntary movement (同)animate being, beast, brute, creature, fauna
- marked by the appetites and passions of the body; "animal instincts"; "carnal knowledge"; "fleshly desire"; "a sensual delight in eating"; "music is the only sensual pleasure without vice" (同)carnal, fleshly, sensual
- (Jungian psychology) the inner self (not the external persona) that is in touch with the unconscious
PrepTutorEJDIC
- (植物に対して)『動物』 / (人間以外の)『動物』,けだもの / (魚・鳥などに対して)哺乳動物(mammal) / けだもの(野獣)のような人 / (比較変化なし)《名詞の前にのみ用いて》動物の,動物性の,動物質の / (知的・精神的に対して)動物的な;肉欲的な
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/05/07 17:21:06」(JST)
wiki en
"GMO" redirects here. For other uses, see GMO (disambiguation).
GloFish, the first genetically modified animal to be sold as a pet
A genetically modified organism (GMO) is an organism whose genetic material has been altered using genetic engineering techniques. Organisms that have been genetically modified include micro-organisms such as bacteria and yeast, insects, plants, fish, and mammals. GMOs are the source of genetically modified foods, and are also widely used in scientific research and to produce goods other than food. The term GMO is very close to the technical legal term, 'living modified organism' defined in the Cartagena Protocol on Biosafety, which regulates international trade in living GMOs (specifically, "any living organism that possesses a novel combination of genetic material obtained through the use of modern biotechnology").
This article focuses on what organisms have been genetically engineered, and for what purposes. The article on genetic engineering focuses on the history and methods of genetic engineering, and on applications of genetic engineering and of GMOs. Both articles cover much of the same ground but with different organizations (sorted by organism in this article; sorted by application in the other). There are separate articles on genetically modified crops, genetically modified food, regulation of the release of genetic modified organisms, and controversies.
Contents
|
Production [edit]
Further information: Genetic engineering, Genetic modification, Horizontal gene transfer, Molecular cloning, Recombinant DNA and Transformation (genetics)
Genetic modification involves the mutation, insertion, or deletion of genes. When genes are inserted, they usually come from a different species, which is a form of horizontal gene transfer. In nature this can occur when exogenous DNA penetrates the cell membrane for any reason. To do this artificially may require attaching the genes to a virus or just physically inserting the extra DNA into the nucleus of the intended host with a very small syringe, or with very small particles fired from a gene gun.[1][2][3] However, other methods exploit natural forms of gene transfer, such as the ability of Agrobacterium to transfer genetic material to plants,[4] or the ability of lentiviruses to transfer genes to animal cells.[5]
History [edit]
Main article: History of genetic engineering
The general principle of producing a GMO is to alter the genetic material of an organism's genome. This may involve mutating, deleting, or adding genetic material. When genetic material from a different species is added, the resulting DNA is called recombinant DNA and the organism is called a transgenic organism. The first recombinant DNA molecules were produced by Paul Berg in 1972.[6][7]
Uses [edit]
GMOs are used in biological and medical research, production of pharmaceutical drugs, experimental medicine (e.g. gene therapy), and agriculture (e.g. golden rice, resistance to herbicides). The term "genetically modified organism" does not always imply, but can include, targeted insertions of genes from one species into another. For example, a gene from a jellyfish, encoding a fluorescent protein called GFP, can be physically linked and thus co-expressed with mammalian genes to identify the location of the protein encoded by the GFP-tagged gene in the mammalian cell. Such methods are useful tools for biologists in many areas of research, including those who study the mechanisms of human and other diseases or fundamental biological processes in eukaryotic or prokaryotic cells.
Plants [edit]
Transgenic plants [edit]
Kenyans examining insect-resistant transgenic Bt corn
Transgenic plants have been engineered for scientific research, to create new colours in plants, and to create different crops.
In research, plants are engineered to help discover the functions of certain genes. One way to do this is to knock out the gene of interest and see what phenotype develops. Another strategy is to attach the gene to a strong promoter and see what happens when it is over expressed. A common technique used to find out where the gene is expressed is to attach it to GUS or a similar reporter gene that allows visualisation of the location.[8]'
Suntory "blue" rose
After thirteen years of collaborative research by an Australian company – Florigene, and a Japanese company – Suntory, created a blue rose (actually lavender or mauve) in 2004.[9] The genetic engineering involved three alterations – adding two genes, and interfering with another. One of the added genes was for the blue plant pigment delphinidin cloned from the pansy.[10] The researchers then used RNA interference (RNAi) technology to depress all color production by endogenous genes by blocking a crucial protein in color production, called dihydroflavonol 4-reductase) (DFR), and adding a variant of that protein that would not be blocked by the RNAi but that would allow the delphinidin to work.[10] The roses are sold worldwide.[11][12] Florigene has also created and sells lavender-colored carnations that are genetically engineered in a similar way.[10]
Simple plants and plant cells have been genetically engineered for production of biopharmaceuticals in bioreactors as opposed to cultivating plants in open fields. Work has been done with duckweed Lemna minor,[13] the algae Chlamydomonas reinhardtii[14] and the moss Physcomitrella patens.[15][16] An Israeli company, Protalix, has developed a method to produce therapeutics in cultured transgenic carrot and tobacco cells.[17] Protalix and its partner, Pfizer, received FDA approval to market its drug Elelyso, a treatment for Gaucher's Disease, in 2012.[18]
GM crops [edit]
Main article: Genetically modified crops
In agriculture, genetically engineered crops are created to possess several desirable traits, such as resistance to pests, herbicides, or harsh environmental conditions, improved product shelf life, increased nutritional value, or production of valuable goods such as drugs (pharming). Since the first commercial cultivation of genetically modified plants in 1996, they have been modified to be tolerant to the herbicides glufosinate and glyphosate, to be resistant to virus damage as in Ringspot virus-resistant GM papaya, grown in Hawaii, and to produce the Bt toxin, an insecticide that is documented as non-toxic to mammals.[19]
Plants, including algae, jatropha, maize, poplars[20] and other plants have been genetically modified for use in producing fuel, known as biofuel.
Critics have objected to GM crops per se on several grounds, including ecological concerns, and economic concerns raised by the fact these organisms are subject to intellectual property law. GM crops also are involved in controversies over GM food with respect to whether food produced from GM crops is safe and whether GM crops are needed to address the world's food needs. See the genetically modified food controversies article for discussion of issues about GM crops and GM food.
Cisgenic plants [edit]
Cisgenesis, sometimes also called intragenesis, is a product designation for a category of genetically engineered plants. A variety of classification schemes have been proposed[21] that order genetically modified organisms based on the nature of introduced genotypical changes rather than the process of genetic engineering.
While some genetically modified plants are developed by the introduction of a gene originating from distant, sexually incompatible species into the host genome, cisgenic plants contain genes that have been isolated either directly from the host species or from sexually compatible species. The new genes are introduced using recombinant DNA methods and gene transfer. Some scientists hope that the approval process of cisgenic plants might be simpler than that of proper transgenics,[22] but it remains to be seen.[23]
Microbes [edit]
Bacteria were the first organisms to be modified in the laboratory, due to their simple genetics.[24] These organisms are now used for several purposes, and are particularly important in producing large amounts of pure human proteins for use in medicine.[25]
Genetically modified bacteria are used to produce the protein insulin to treat diabetes.[26] Similar bacteria have been used to produce biofuels,[27] clotting factors to treat haemophilia,[28] and human growth hormone to treat various forms of dwarfism.[29][30]
In addition, various genetically engineered micro-organisms are routinely used as sources of enzymes for the manufacture of a variety of processed foods. These include alpha-amylase from bacteria, which converts starch to simple sugars, chymosin from bacteria or fungi that clots milk protein for cheese making, and pectinesterase from fungi which improves fruit juice clarity.[31]
Mammals [edit]
Some chimeras, like the blotched mouse shown, are created through genetic modification techniques like gene targeting.
Genetically modified mammals are an important category of genetically modified organisms.[32] Ralph L. Brinster and Richard Palmiter developed the techniques responsible for transgenic mice, rats, rabbits, sheep, and pigs in the early 1980s, and established many of the first transgenic models of human disease, including the first carcinoma caused by a transgene. The process of genetically engineering animals is a slow, tedious, and expensive process. However, new technologies are making genetic modifications easier and more precise.[33]
The first transgenic (genetically modified) animal was produced by injecting DNA into mouse embryos then implanting the embryos in female mice.[34]
Genetically modified animals currently being developed can be placed into six different broad classes based on the intended purpose of the genetic modification:
- to research human diseases (for example, to develop animal models for these diseases);
- to produce industrial or consumer products (fibres for multiple uses;
- to produce products intended for human therapeutic use (pharmaceutical products or tissue for implantation);
- to enrich or enhance the animals' interactions with humans (hypo-allergenic pets);
- to enhance production or food quality traits (faster growing fish, pigs that digest food more efficiently);
- to improve animal health (disease resistance)[35]
Research use [edit]
Transgenic animals are used as experimental models to perform phenotypic and for testing in biomedical research.[36]
Genetically modified (genetically engineered) animals are becoming more vital to the discovery and development of cures and treatments for many serious diseases. By altering the DNA or transferring DNA to an animal, we can develop certain proteins that may be used in medical treatment. Stable expressions of human proteins have been developed in many animals, including sheep, pigs, and rats. Human-alpha-1-antitrypsin,[37] which has been tested in sheep and is used in treating humans with this deficiency and transgenic pigs with human-histo-compatibility have been studied in the hopes that the organs will be suitable for transplant with less chances of rejection.
Scientists have genetically engineered several organisms, including some mammals, to include green fluorescent protein (GFP) for medical research purposes (Chalfie, Shimoura, and Tsien were awarded the Nobel prize in 2008 for GFP[38]). For example fluorescent pigs have been bred in the US in 2000,[39] in Korea in 2002,[40] in Taiwan in 2006,[41] in China in 2008[42] and Japan in 2009.[43] These pigs were bred to study human organ transplants,[42] regenerating ocular photoreceptor cells,[44] neuronal cells in the brain,[44] regenerative medicine via stem cells,[45] tissue engineering,[43] and other diseases. In 2011 a Japanese-American Team created green-fluorescent cats in order to find therapies for HIV/AIDS and other diseases[46] as Feline immunodeficiency virus (FIV) is related to HIV.[47]
In 2009, scientists in Japan announced that they had successfully transferred a gene into a primate species (marmosets) and produced a stable line of breeding transgenic primates for the first time.[48][49] Their first research target for these marmosets was Parkinson's disease, but they were also considering Amyotrophic lateral sclerosis and Huntington's disease.[50]
Producing human therapeutics [edit]
Within the field known as pharming, intensive research has been conducted to develop transgenic animals that produce biotherapeutics.[51] On 6 February 2009, the U.S. Food and Drug Administration approved the first human biological drug produced from such an animal, a goat. The drug, ATryn, is an anticoagulant which reduces the probability of blood clots during surgery or childbirth. It is extracted from the goat's milk.[52]
Production or food quality traits [edit]
Enviropig is a genetically enhanced line of Yorkshire pigs created with the capability of digesting plant phosphorus more efficiently than conventional Yorkshire pigs and dubbed them Enviropig.[53] These pigs produce the enzyme phytase, which breaks down the indigestible phosphorus, in their saliva. The enzyme was introduced into the pig chromosome by pronuclear microinjection. With this enzyme, Enviropig is able to digest cereal grain phosphorus, so there is then no need to supplement the pigs' diet with either phosphate minerals or commercially produced phytase, and less phosphorus is lost in the manure.[53] Enviropig would reduce feed costs because farmers would not need to purchase feed including the phytase, and it also would reduce the potential of water pollution since the Enviropig excretes from 30 to 70.7% less phosphorus in manure depending upon the age and diet.[53][54] The lower concentrations of phosphorus in surface runoff reduces algal growth, because phosphorus is the limiting nutrient for algae.[53] Because algae consume large amounts of oxygen, it can result in dead zones for fish. This would not only be advantageous for the waters surrounding the pigs, but also for the water neighboring the areas which use the manure for fertilizers. There are no current regulations or pending approvals on the Enviropig for human consumption in the United States.[55] In February 2010, Environment Canada determined that Enviropigs are in compliance with the Canadian Environmental Protection Act and can be produced outside of the research context in controlled facilities where they are segregated from other animals.[56]
In 2011, Chinese scientists generated dairy cows genetically engineered with genes for human beings to produce milk that would be the same as human breast milk.[57] This could potentially benefit mothers who cannot produce breast milk but want their children to have breast milk rather than formula. Aside from milk production, the researchers claim these transgenic cows to be identical to regular cows.[58] Two months later scientists from Argentina presented Rosita, a transgenic cow incorporating two human genes, to produce milk with similar properties as human breast milk.[59] In 2012, researchers from New Zealand also developed a genetically engineered cow that produced allergy-free milk.[60]
In 2006, a pig was engineered to produce omega-3 fatty acids through the expression of a roundworm gene.[61]
Goats have been genetically engineered to produce milk with strong spiderweb-like silk proteins in their milk.[62]
Genetically modified fish have been developed with promoters driving an over-production of growth hormone for use in the aquaculture industry to increase the speed of development and potentially reduce fishing pressure on wild stocks. AquaBounty, a biotechnology company working on bringing a GM salmon to market, claims that their GM AquAdvantage salmon can mature in half the time it takes non-GM salmon and achieves twice the size.[63] AquaBounty has applied for regulatory approval to market their GM salmon in the US. As of May 2012 the application was still pending.[64]
Human gene therapy [edit]
Gene therapy,[65] uses genetically modified viruses to deliver genes that can cure disease in humans. Although gene therapy is still relatively new, it has had some successes. It has been used to treat genetic disorders such as severe combined immunodeficiency,[66] and Leber's congenital amaurosis.[67] Treatments are also being developed for a range of other currently incurable diseases, such as cystic fibrosis,[68] sickle cell anemia,[69] Parkinson's disease,[70][71] cancer,[72][73][74] diabetes[75], heart disease[76] and muscular dystrophy.[77] Current gene therapy technology only targets the non-reproductive cells meaning that any changes introduced by the treatment can not be transmitted to the next generation. Gene therapy targeting the reproductive cells—so-called "Germ line Gene Therapy"—is very controversial and is unlikely to be developed in the near future.
Insects [edit]
Fruit flies [edit]
In biological research, transgenic fruit flies (Drosophila melanogaster) are model organisms used to study the effects of genetic changes on development.[78] Fruit flies are often preferred over other animals due to their short life cycle, low maintenance requirements, and relatively simple genome compared to many vertebrates.
Mosquitoes [edit]
In 2010, scientists created "malaria-resistant mosquitoes" in the laboratory.[79][80][81] The World Health Organisation estimated that Malaria killed almost one million people in 2008.[82] Genetically modified male mosquitoes containing a lethal gene have been developed in order to combat the spread of Dengue fever.[83] Aedes aegypti mosquitoes, the single most important carrier of dengue fever, were reduced by 80% in a 2010 trial of these GM mosquitoes in the Cayman Islands.[84][85] Between 50 and 100 million people are affected by Dengue fever every year and 40,000 people die from it.[86]
Bollworms [edit]
A strain of Pectinophora gossypiella (Pink bollworm) has been developed that contains a fluorescent marker in their DNA. This allows researchers to monitor bollworms that have been sterilized by radiation and released in order to reduce bollworm infestation.[86][87]
Aquatic Life [edit]
Cnidarians [edit]
Cnidarians such as Hydra and the sea anemone Nematostella vectensis have become attractive model organisms to study the evolution of immunity and certain developmental processes. An important technical breakthrough was the development of procedures for generation of stably transgenic hydras and sea anemones by embryo microinjection.[88]
Fish [edit]
GM fish are used for scientific research and as pets, and are being considered for use as food and as aquatic pollution sensors.
Genetically engineered fish are widely used in basic research in genetics and development. Two species of fish, zebrafish and medaka, are most commonly modified because they have optically clear chorions (shells), rapidly develop, and the 1-cell embryo is easy to see and microinject with transgenic DNA.[89]
The GloFish is a patented[90] brand of genetically modified (GM) fluorescent zebrafish with bright red, green, and orange fluorescent color. Although not originally developed for the ornamental fish trade, it became the first genetically modified animal to become publicly available as a pet when it was introduced for sale in 2003.[91] They were quickly banned for sale in California.[92]
Genetically modified fish have been developed with promoters driving an over-production of "all fish" growth hormone for use in the aquaculture industry to increase the speed of development and potentially reduce fishing pressure on wild stocks. This has resulted in dramatic growth enhancement in several species, including salmon,[93] trout[94] and tilapia.[95] AquaBounty, a biotechnology company working on bringing a GM salmon to market, claims that their GM AquAdvantage salmon can mature in half the time it takes non-GM salmon and achieves twice the size.[63] AquaBounty has applied for regulatory approval to market their GM salmon in the US. As of December 2012 the application was still pending.[64][96]
Several academic groups have been developing GM zebrafish to detect aquatic pollution. The lab that originated the GloFish discussed above originally developed them to change color in the presence of pollutants, to be used as environmental sensors.[97][98] A lab at University of Cincinnati has been developing GM zebrafish for the same purpose,[99][100] as has a lab at Tulane University.[101]
Regulation [edit]
Main article: Regulation of genetic engineering
The regulation of genetic engineering concerns the approaches taken by governments to assess and manage the risks associated with the use of genetic engineering technology and the development and release of genetically modified organisms (GMO), including genetically modified crops and genetically modified fish. There are differences in the regulation of GMOs between countries, with some of the most marked differences occurring between the USA and Europe.[102] Regulation varies in a given country depending on the intended use of the products of the genetic engineering. For example, a crop not intended for food use is generally not reviewed by authorities responsible for food safety.[103]
Controversy [edit]
Main article: Genetically modified food controversies
There are controversies around GMOs on several levels, including whether making them is ethical, whether food produced with them is safe, whether such food should be labeled and if so how, whether agricultural biotech is needed to address world hunger now or in the future, and more specifically to GM crops—intellectual property and market dynamics; environmental effects of GM crops; and GM crops' role in industrial agricultural more generally.
See also [edit]
- Timeline of genetically modified organisms
- Detection of genetically modified organisms
- Reading Scientific Services (detecting GMOs)
- BioSteel
- Chimera (genetics)
- Gene flow
- Gene pool
- Genetic erosion
- Horizontal gene transfer
- Non-GMO Project
- Organic farming
- SMART breeding
- Sperm-mediated gene transfer
- Synthetic biology
References [edit]
- ^ Cornell Chronicle, May 14, 1987, page 3.Biologists invent gun for shooting cells with DNA
- ^ Sanford JC et al (1987) Delivery of substances into cells and tissues using a particle bombardment process. Journal of Particulate Science and Technology 5:27-37.
- ^ Klein, TM et al (1987) High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327:70-73.
- ^ Lee LY, Gelvin SB (February 2008). "T-DNA binary vectors and systems". Plant Physiol. 146 (2): 325–332. doi:10.1104/pp.107.113001. OCLC 1642351. PMC 2245830. PMID 18250230.
- ^ Park F (October 2007). "Lentiviral vectors: are they the future of animal transgenesis?". Physiol. Genomics 31 (2): 159–173. doi:10.1152/physiolgenomics.00069.2007. OCLC 37367250. PMID 17684037.
- ^ Jackson, DA; Symons, RH; Berg, P (1 October 1972). "Biochemical Method for Inserting New Genetic Information into DNA of Simian Virus 40: Circular SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose Operon of Escherichia coli". PNAS 69 (10): 2904–2909. Bibcode:1972PNAS...69.2904J. doi:10.1073/pnas.69.10.2904. PMC 389671. PMID 4342968.
- ^ M. K. Sateesh (25 August 2008). Bioethics And Biosafety. I. K. International Pvt Ltd. pp. 456–. ISBN 978-81-906757-0-3. Retrieved 27 March 2013.
- ^ Jefferson R. A. Kavanagh T. A. Bevan M. W. (1987). "GUS fusions: beta-glucuronidase as a sensitive and versatile gene fusion marker in higher plants". EMBO journal 6 (13): 3901–3907. ISSN 0261-4189. PMC 553867. PMID 3327686.
- ^ Nosowitz, Dan (15 September 2011) Suntory Creates Mythical Blue (Or, Um, Lavender-ish) Rose Popular Science, Retrieved 30 August 2012
- ^ a b c Phys.Org website. April 4, 2005 Plant gene replacement results in the world's only blue rose
- ^ Kyodo (11 September 2011 Suntory to sell blue roses overseas The Japan Times, Retrieved 30 August 2012
- ^ Wired Report 2011
- ^ Gasdaska JR et al (2003) Advantages of Therapeutic Protein Production in the Aquatic Plant Lemna. BioProcessing Journal Mar/Apr 2003 pp 49–56 [1]
- ^ (10 December 2012) Engineering algae to make complex anti-cancer 'designer' drug PhysOrg, Retrieved 15 April 2013
- ^ Büttner-Mainik, A., et al (2011): Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnology Journal 9, 373–383. [2]
- ^ Baur, A., R. Reski, G. Gorr (2005): Enhanced recovery of a secreted recombinant human growth factor using stabilizing additives and by co-expression of human serum albumin in the moss Physcomitrella patens. Plant Biotech. J. 3, 331–340 [3]
- ^ Protalix website – technology platform
- ^ Gali Weinreb and Koby Yeshayahou for Globes May 2, 2012. FDA approves Protalix Gaucher treatment
- ^ http://www.agf.gov.bc.ca/pesticides/infosheets/bt.pdf. Retrieved 21 January 2011
- ^ Hope, Alan (3 April 2013), News in brief: The Bio Safety Council...", Flanders Today, Page 2; In 2013, the Flemish Institute for Biotechnology was supervising a trial of 448 poplar trees genetically engineered to produce less lignin so that they would be more suitable for conversion into bio-fuels.
- ^ Nielsen, K. M. (2003). "Transgenic organisms—time for conceptual diversification?". Nature Biotechnology 21 (3): 227–228. doi:10.1038/nbt0303-227. PMID 12610561. edit
- ^ Schouten, H.; Krens, F.; Jacobsen, E. (2006). "Cisgenic plants are similar to traditionally bred plants: international regulations for genetically modified organisms should be altered to exempt cisgenesis". EMBO Reports 7 (8): 750–753. doi:10.1038/sj.embor.7400769. PMC 1525145. PMID 16880817. edit
- ^ Prins, T.W. and Kok, E.J. (2010) Food and feed safety aspects of cisgenic crop plant varieties Report 2010.001, Project number: 120.72.667.01, RIKILT – Institute of Food Safety, Netherlands. Retrieved 6 September 2010.
- ^ Melo, Eduardo O.; Canavessi, Aurea M. O.; Franco, Mauricio M.; Rumpf, Rodolpho (2007). "Animal transgenesis: state of the art and applications". J. Appl. Genet. 48 (1): 47–61. doi:10.1007/BF03194657. PMID 17272861. Archived from the original on 26 September 2009.
- ^ Leader, Benjamin; Baca, Qentin J.; Golan, David E. (January 2008). "Protein therapeutics: a summary and pharmacological classification". Nat Rev Drug Discov. A guide to drug discovery 7 (1): 21–39. doi:10.1038/nrd2399. PMID 18097458.
Leader 2008 — Fee required for access to full text. - ^ Walsh, Gary (April 2005). "Therapeutic insulins and their large-scale manufacture". Appl. Microbiol. Biotechnol. 67 (2): 151–159. doi:10.1007/s00253-004-1809-x. PMID 15580495.
Walsh 2005 — Fee required for access to full text. - ^ Summers, Rebecca (24 April 2013) Bacteria churn out first ever petrol-like biofuel New Scientist, Retrieved 27 April 2013
- ^ Pipe, Steven W. (May 2008). "Recombinant clotting factors". Thromb. Haemost. 99 (5): 840–850. doi:10.1160/TH07-10-0593. PMID 18449413.
- ^ Bryant, Jackie; Baxter, Louise; Cave, Carolyn B.; Milne, Ruairidh; Bryant, Jackie (2007). "Recombinant growth hormone for idiopathic short stature in children and adolescents". In Bryant, Jackie. Cochrane Database Syst Rev (3): CD004440. doi:10.1002/14651858.CD004440.pub2. PMID 17636758.
Bryant 2007 — Fee required for access to full text. - ^ Baxter L, Bryant J, Cave CB, Milne R (2007). "Recombinant growth hormone for children and adolescents with Turner syndrome". In Bryant, Jackie. Cochrane Database Syst Rev (1): CD003887. doi:10.1002/14651858.CD003887.pub2. PMID 17253498.
- ^ Panesar, Pamit et al (2010) "Enzymes in Food Processing: Fundamentals and Potential Applications", Chapter 10, I K International Publishing House, ISBN 978-9380026336
- ^ EFSA (2012). Genetically modified animals. Europe: EFSA.http://www.efsa.europa.eu/en/topics/topic/gmanimals.htm.
- ^ Murray, Joo (20). Genetically modified animals. Canada: Brainwaving.http://www.brainwaving.com/2010/07/28/genetically-modified-animals/.
- ^ Jaenisch, R. and Mintz, B. (1974). "Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA.". Proc. Natl. Acad. Sci. 71 (4): 1250–1254. Bibcode:1974PNAS...71.1250J. doi:10.1073/pnas.71.4.1250. PMC 388203. PMID 4364530.
- ^ rudinko, larisa (20). Guidance for industry. USA: Center for veterinary medicine Link.
- ^ Sathasivam K, Hobbs C, Mangiarini L, et al. (June 1999). [http: //journals.royalsociety.org/openurl.asp?genre=article&issn=0962-8436&volume=354&issue=1386&spage=963 "Transgenic models of Huntington's disease"]. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 354 (1386): 963–9. doi:10.1098/rstb.1999.0447. PMC 1692600. PMID 10434294.
- ^ Spencer, L; Humphries, J; Brantly, M. (12 May 2005). "Antibody Response to Aerosolized Transgenic Human Alpha1-Antitrypsin". New England Journal of Medicine 352: 19. Retrieved 28 April 2011.
- ^ "The Nobel Prize in Chemistry 2008". The Official Web Site of the Nobel Foundation. Retrieved 2012-08-31.
- ^ Cabot, R. A.; Kühholzer, B.; Chan, A. W. S.; Lai, L.; Park, K. -W.; Chong, K. -Y.; Schatten, G.; Murphy, C. N. et al. (2001). "Transgenic Pigs Produced Using in Vitro Matured Oocytes Infected with a Retroviral Vector". Animal Biotechnology 12 (2): 205–214. doi:10.1081/ABIO-100108347. PMID 11808636.
|displayauthors=suggested (help) edit - ^ Lai, L.; Park, K. W.; Cheong, H. T.; k�Hholzer, B.; Samuel, M.; Bonk, A.; Im, G. S.; Rieke, A. et al. (2002). "Transgenic pig expressing the enhanced green fluorescent protein produced by nuclear transfer using colchicine-treated fibroblasts as donor cells". Molecular Reproduction and Development 62 (3): 300–306. doi:10.1002/mrd.10146. PMID 12112592.
|displayauthors=suggested (help) edit - ^ Hogg, Chris (12 January 2006) Taiwan Breeds Green-Glowing Pigs BBC, Retrieved 31 August 2012
- ^ a b Staff (8 January 2008) Fluorescent Chinese pig passes on trait to offspring AFP, Retrieved 31 August 2012
- ^ a b Kawarasaki, T.; Uchiyama, K.; Hirao, A.; Azuma, S.; Otake, M.; Shibata, M.; Tsuchiya, S.; Enosawa, S. et al. (2009). "Profile of new green fluorescent protein transgenic Jinhua pigs as an imaging source". Journal of Biomedical Optics 14 (5): 054017. doi:10.1117/1.3241985. PMID 19895119.
|displayauthors=suggested (help) edit - ^ a b Randall S. et al (2008) Genetically Modified Pigs for Medicine and Agriculture Biotechnology and Genetic Engineering Reviews – Vol. 25, 245–266, Retrieved 31 August 2012
- ^ Staff (2006) NTU produces green fluorescent pigs for medical research Taiwan Central News Agency, Retrieved 31 August 2012
- ^ Wongsrikeao P, Saenz D, Rinkoski T, Otoi T, Poeschla E (2011). "Antiviral restriction factor transgenesis in the domestic cat". Nature Methods 8 (10): 853–9. doi:10.1038/nmeth.1703. PMID 21909101.
- ^ Staff (3 April 2012) Biology of HIV National Institute of Allergy and Infectious Diseases, Retrieved 31 August 2012.
- ^ Sasaki, E.; Suemizu, H.; Shimada, A.; Hanazawa, K.; Oiwa, R.; Kamioka, M.; Tomioka, I.; Sotomaru, Y. et al. (2009). "Generation of transgenic non-human primates with germline transmission". Nature 459 (7246): 523–527. Bibcode:2009Natur.459..523S. doi:10.1038/nature08090. PMID 19478777.
|displayauthors=suggested (help) edit - ^ Schatten, G.; Mitalipov, S. (2009). "Developmental biology: Transgenic primate offspring". Nature 459 (7246): 515–516. Bibcode:2009Natur.459..515S. doi:10.1038/459515a. PMC 2777739. PMID 19478771. edit
- ^ Cyranoski, D. (2009). "Marmoset model takes centre stage". Nature 459 (7246): 492–492. doi:10.1038/459492a. PMID 19478751. edit
- ^ Louis-Marie Houdebine (2009) Production of Pharmeceutical by transgenic animals. Comparative Immunology, Microbiology & Infectious Diseases 32(2): 107–121 [4]
- ^ Britt Erickson, 10 February 2009, for Chemical & Engineering News. FDA Approves Drug From Transgenic Goat Milk Accessed October 6, 2012
- ^ a b c d Guelph(2010). Enviropig. Canada: http://www.uoguelph.ca/enviropig/index.shtml/.
- ^ Canada. "Enviropig — Environmental Benefits | University of Guelph". Uoguelph.ca. Retrieved 8 March 2010.
- ^ [www.fda.org United States FDA.]
- ^ Lori (19 February 2010). "Enviropig Moves Ahead | University of Guelph". Uoguelph.ca. Retrieved 8 March 2010.
- ^ stevenson, heidi(2011). Scientists Use Human Genes in Animals, So Cows Produce Human-Like Milk—Or Do They? USA:http://www.gaia-health.com/articles401/000433-human-genes-cows-produce-human-milk.shtml/.
- ^ Classical Medicine Journal (14 April 2010). "Genetically modified cows producing human milk.".
- ^ Yapp, Robin (11 June 2011). "Scientists create cow that produces 'human' milk". The Daily Telegraph (London). Retrieved 15 June 2012.
- ^ Jabed, A.; Wagner, S.; McCracken, J.; Wells, D. N.; Laible, G. (2012). "Targeted microRNA expression in dairy cattle directs production of -lactoglobulin-free, high-casein milk". Proceedings of the National Academy of Sciences. doi:10.1073/pnas.1210057109. edit
- ^ Lai L et al. (2006). "Generation of cloned transgenic pigs rich in omega-3 fatty acids". Nature Biotechnology 24 (4): 435–436. doi:10.1038/nbt1198. PMC 2976610. PMID 16565727. Retrieved 2009-03-29.
- ^ Zyga, Lisa(2010). Scientist bred goats that produce spider silk. Link.
- ^ a b {AquAdvantage salmon}[5]
- ^ a b Andrew Pollack for the New York Times. "An Entrepreneur Bankrolls a Genetically Engineered Salmon" Published: May 21, 2012. Accessed October 7, 2012
- ^ Selkirk SM (October 2004). "Gene therapy in clinical medicine". Postgrad Med J 80 (948): 560–70. doi:10.1136/pgmj.2003.017764. PMC 1743106. PMID 15466989.
- ^ Cavazzana-Calvo M, Fischer A (June 2007). "Gene therapy for severe combined immunodeficiency: are we there yet?". J. Clin. Invest. 117 (6): 1456–65. doi:10.1172/JCI30953. PMC 1878528. PMID 17549248.
- ^ Richards, Sabrina (6 November 2012) Gene Therapy Arrives in Europe The Scientist, Retrieved 15 April 2013
- ^ Rosenecker J, Huth S, Rudolph C (October 2006). "Gene therapy for cystic fibrosis lung disease: current status and future perspectives". Curr. Opin. Mol. Ther. 8 (5): 439–45. PMID 17078386.
- ^ Persons DA, Nienhuis AW (July 2003). "Gene therapy for the hemoglobin disorders". Curr. Hematol. Rep. 2 (4): 348–55. PMID 12901333.
- ^ Lewitt, P. A.; Rezai, A. R.; Leehey, M. A.; Ojemann, S. G.; Flaherty, A. W.; Eskandar, E. N.; Kostyk, S. K.; Thomas, K. et al. (2011). "AAV2-GAD gene therapy for advanced Parkinson's disease: A double-blind, sham-surgery controlled, randomised trial". The Lancet Neurology 10 (4): 309–319. doi:10.1016/S1474-4422(11)70039-4. PMID 21419704.
|displayauthors=suggested (help) edit - ^ Gallaher, James Gene therapy 'treats' Parkinson's disease BBC News Health, 17 March 2011. Retrieved 24 April 2011
- ^ Urbina, Zachary (12 February 2013) Genetically Engineered Virus Fights Liver Cancer United Academics, Retrieved 15 February 2013
- ^ "Treatment for Leukemia Is Showing Early Promise". The New York Times. Associated Press. August 11, 2011. p. A15. Retrieved 21 January 2013.
- ^ Coghlan, Andy (26 March 2013) Gene therapy cures leukaemia in eight days The New Scientist, Retrieved 15 April 2013
- ^ Staff (13 February 2013) Gene therapy cures diabetic dogs New Scientist, Retrieved 15 February 2013
- ^ (30 April 2013) New gene therapy trial gives hope to people with heart failure British Heart Foundation, Retrieved 5 may 2013
- ^ Foster K, Foster H, Dickson JG (December 2006). "Gene therapy progress and prospects: Duchenne muscular dystrophy". Gene Ther. 13 (24): 1677–85. doi:10.1038/sj.gt.3302877. PMID 17066097.
- ^ First Transgenic Mice and Fruit Flies
- ^ Gallagher, James GM mosquitoes offer malaria hope BBC News, Health, 20 April 2011. Retrieved 22 April 2011
- ^ Corby-Harris, V.; Drexler, A.; Watkins De Jong, L.; Antonova, Y.; Pakpour, N.; Ziegler, R.; Ramberg, F.; Lewis, E. E. et al. (2010). "Activation of Akt Signaling Reduces the Prevalence and Intensity of Malaria Parasite Infection and Lifespan in Anopheles stephensi Mosquitoes". In Vernick, Kenneth D. PLoS Pathogens 6 (7): e1001003. doi:10.1371/journal.ppat.1001003. PMC 2904800. PMID 20664791.
|displayauthors=suggested (help) edit - ^ Windbichler, N.; Menichelli, M.; Papathanos, P. A.; Thyme, S. B.; Li, H.; Ulge, U. Y.; Hovde, B. T.; Baker, D. et al. (2011). "A synthetic homing endonuclease-based gene drive system in the human malaria mosquito". Nature 473 (7346): 212–215. doi:10.1038/nature09937. PMC 3093433. PMID 21508956.
|displayauthors=suggested (help) edit - ^ World Health Organization, Malaria, Key Facts Retrieved 22 April 2011
- ^ Wise De Valdez, M. R.; Nimmo, D.; Betz, J.; Gong, H. -F.; James, A. A.; Alphey, L.; Black, W. C. (2011). "Genetic elimination of dengue vector mosquitoes". Proceedings of the National Academy of Sciences 108 (12): 4772. doi:10.1073/pnas.1019295108. edit
- ^ Harris, A. F.; Nimmo, D.; McKemey, A. R.; Kelly, N.; Scaife, S.; Donnelly, C. A.; Beech, C.; Petrie, W. D. et al. (2011). "Field performance of engineered male mosquitoes". Nature Biotechnology 29 (11): 1034–1037. doi:10.1038/nbt.2019. PMID 22037376.
|displayauthors=suggested (help) edit - ^ Staff (March 2011) Cayman demonstrates RIDL potential Oxitec Newsletter, March 2011. Retrieved 20 September 2011
- ^ a b Nicholls, Henry (14 September 2011) Swarm troopers: Mutant armies waging war in the wild The New Scientist. Retrieved 20 September 2011
- ^ Staff Pectinophora gossypiella (pink bollworm) OX1138 Oxitec. Retrieved 30 September 2011
- ^ Wittlieb J, Khalturin K, Lohmann JU, Anton-Erxleben F and Bosch TCG (2006). "Transgenic Hydra allow in vivo tracking of individual stem cells during morphogenesis". Proc. Natl. Acad. Sci. USA 103 (16): 6208–6211. Bibcode:2006PNAS..103.6208W. doi:10.1073/pnas.0510163103. PMC 1458856. PMID 16556723.
- ^ Hackett, P.B., Ekker, S.E. and Essner, J.J. (2004) Applications of transposable elements in fish for transgenesis and functional genomics. Fish Development and Genetics (Z. Gong and V. Korzh, eds.) World Scientific, Inc., Chapter 16, 532–580.
- ^ Published PCT Application WO2000049150 "Chimeric Gene Constructs for Generation of Fluorescent Transgenic Ornamental Fish." National University of Singapore [6]
- ^ Eric Hallerman Glofish, The First GM Animal Commercialized: Profits amid Controversy. June, 2004. Accessed September 3, 2012.[7]
- ^ Schuchat S. (2003) Why GloFish won't glow in California. San Francisco Chronicle.[8]
- ^ Shao Jun Du et al. (1992) Growth Enhancement in Transgenic Atlantic Salmon by the Use of an "All Fish" Chimeric Growth Hormone Gene Construct. Nature Biotechnology 10, 176–181 [9]
- ^ Devlin RF et al (2001) Growth of domesticated transgenic fish. Nature 409, 781–782 [10]
- ^ Rahman MA et al. (2001) Growth and nutritional trials on transgenic Nile tilapia containing an exogenous fish growth hormone gene. Journal of Fish Biology 59(1):62–78 [11]
- ^ Staff (26 December 2012) Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning a Genetically Engineered Atlantic Salmon; Availability Federal Register / Vol. 77, No. 247 / Wednesday, December 26, 2012 / Notices, Retrieved 2 January 2013
- ^ National University of Singapore Enterprise webpage
- ^ Zebra Fish as Pollution Indicators Page last modified on 31 July 2001. Accessed October 2012
- ^ Carvan MJ et al (2000) Transgenic zebrafish as sentinels for aquatic pollution. Ann N Y Acad Sci. 2000;919:133–47 [12]
- ^ Nebert DW et al (2002) Use of Reporter Genes and Vertebrate DNA Motifs in Transgenic Zebrafish as Sentinels for Assessing Aquatic Pollution. Environmental Health Perspectives 110(1):A15 | January 2002 [13]
- ^ Mattingly CJ et al (2001) Green fluorescent protein (GFP) as a marker of aryl hydrocarbon receptor (AhR) function in developing zebrafish (Danio rerio). Environ Health Perspect. 2001 Aug;109(8):845–9 [14]
- ^ Gaskell, G.; Bauer, M. W.; Durant, J.; Allum, N. C. (1999). "Worlds Apart? The Reception of Genetically Modified Foods in Europe and the U.S". Science 285 (5426): 384–387. doi:10.1126/science.285.5426.384. PMID 10411496. edit
- ^ PotatoPro
External links [edit]
- Everything you wanted to know about GM organisms — Provided by New Scientist.
- Transgenic Organism Research
- International Society for Transgenic Technologies (ISTT)
- GMO-Compass: Information on genetically modified organisms
- Co-Extra: Research on co-existence and traceability of GM and non-GM supply chains
- ISAAA Knowledge Center: Information on genetically modified organisms
- EFSA GMO Panel deliberations on the Austrian report "Biological effects of transgenic maize NK603 x MON 810 fed in long term reproduction studies in mice" (Part of the minutes of the plenary meeting held on 3–4 December 2008, see on page 9)
- Do Seed Companies Control GM Crop Research?, Scientific American, August 2009.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 慢性骨髄性白血病の細胞生物学および分子生物学 cellular and molecular biology of chronic myeloid leukemia
- 2. 運動単位数推定法（MUNE） motor unit number estimation mune
- 3. 動物およびヒトによる咬傷の初期マネージメント initial management of animal and human bites
- 4. 筋萎縮性側索硬化症の病態修飾療法 disease modifying treatment of amyotrophic lateral sclerosis
- 5. 高血圧における左室肥大の定義および病因 definition and pathogenesis of left ventricular hypertrophy in hypertension
English Journal
- Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells.
- Lynch JN, Donermeyer DL, Weber KS, Kranz DM, Allen PM.SourceDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, United States.
- Molecular immunology.Mol Immunol.2013 Mar;53(3):283-94. doi: 10.1016/j.molimm.2012.08.020. Epub 2012 Sep 14.
- Changes in the peptide and MHC molecules have been extensively examined for how they alter T cell activation, but many fewer studies have examined the TCR. Structural studies of how TCR differences alter T cell specificity have focused on broad variation in the CDR3 loops. However, changes in the CD
- PMID 22982754
- Analysis of Ig gene hypermutation in Ung(-/-)Polh(-/-) mice suggests that UNG and A:T mutagenesis pathway target different U:G lesions.
- Li S, Zhao Y, Wang JY.SourceState Key Laboratory of AgroBiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100094, China.
- Molecular immunology.Mol Immunol.2013 Mar;53(3):214-7. doi: 10.1016/j.molimm.2012.08.009. Epub 2012 Sep 4.
- The activation-induced cytidine deaminase (AID) initiates Ig gene hypermutation by converting cytosine to uracil (U) and generating a U:G lesion. Genetic and biochemical studies suggest that the AID-triggered U:G lesions are processed by three mutagenic pathways to induce mutations at both C:G and A
- PMID 22960197
- A touch screen-automated cognitive test battery reveals impaired attention, memory abnormalities, and increased response inhibition in the TgCRND8 mouse model of Alzheimer's disease.
- Romberg C, Horner AE, Bussey TJ, Saksida LM.SourceDepartment of Experimental Psychology, University of Cambridge, Cambridge, UK. carola.romberg@gmail.com
- Neurobiology of aging.Neurobiol Aging.2013 Mar;34(3):731-44. doi: 10.1016/j.neurobiolaging.2012.08.006. Epub 2012 Sep 5.
- Transgenic mouse models of Alzheimer's disease (AD) with abundant β-amyloid develop memory impairments. However, multiple nonmnemonic cognitive domains such as attention and executive control are also compromised early in AD individuals, but have not been routinely assessed in animal models. Here,
- PMID 22959727
Japanese Journal
- Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection
- Yamashita Taro,Honda Masao,Kaneko Shuichi
- Journal of Gastroenterology and Hepatology 26(6), 960-964, 2011-06
- … Recent developments and advances in HCV replication systems in vitro and in vivo, transgenic animal models, and gene expression profiling approaches have provided novel insights into the mechanisms of HCV replication. …
- NAID 120003141912
- In vitro Culture of Testicular and Ovarian Gonocytes Obtained from 19-day Incubated Chicken Embryos and Subsequent Colonization into Gonads of Recipient Embryos
- NAITO Mitsuru,HARUMI Takashi,KUWANA Takashi
- The journal of poultry science 48(2), 112-118, 2011-04-25
- NAID 10028047602
Related Links
- A transgenic animal is one that carries a foreign gene that has been deliberately inserted into its genome. The foreign gene is constructed using recombinant DNA methodology. In addition to the gene itself, the DNA usually includes other ...
- 21 Aug 2002 ... The majority of transgenic animals produced so far are mice, the animal that pioneered the technology. The first successful transgenic animal was a mouse.6 A few years later, it was followed by rabbits, pigs, sheep, and ...
Related Pictures
★リンクテーブル★
| リンク元 | 「genetically modified animal」「transgenic founder animal」「遺伝子導入動物」 |
| 関連記事 | 「transgenic」「animal」 |
「genetically modified animal」
「transgenic founder animal」
「遺伝子導入動物」
「transgenic」
- adj.
- 遺伝子導入の、形質転換の、遺伝子組換えの、トランスジェニック
- 関
- congenic、gene transfer、genetic transformation、Tg、transform、transformation、transforming、transgenesis、transgenically
「animal」
- n.
- adj.
- 動物性の